Metabonomics in study of Parkinson's disease biomarkers / 中华神经医学杂志
Chinese Journal of Neuromedicine
; (12): 418-420, 2016.
Article
en Zh
| WPRIM
| ID: wpr-1034368
Biblioteca responsable:
WPRO
ABSTRACT
Parkinson's disease (PD) is a common neurological degenerative diseases.Neuron degeneration process is irreversible;therefore,the correct diagnosis is critical and reliable biomarkers are urgently needed.With the development of molecular biology,some nonspecific biomarker detection methods,such as metabolomics,have been used in the study ofPD.Metabonomics provides a technology and a new technical platform for testing comprehensive metabolites of PD.Metabonomics is very important for biomarker screening in PD.In this paper,the concept,research methods and research progress of metabonomics in PD are reviewed.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Neuromedicine
Año:
2016
Tipo del documento:
Article